Innate Pharma S.A. (EPA:IPH)
France
· Delayed Price · Currency is EUR 1.354
-0.020 (-1.46%)
Mar 6, 2026, 12:34 PM CET
Innate Pharma Employees
Innate Pharma had 174 employees as of June 30, 2025. The number of employees decreased by 7 or -3.87% since the number was reported on December 31, 2024.
Employees
174
Change
-7
Growth
-3.87%
Revenue / Employee
€72,621
Profits / Employee
€264,661
Market Cap
128.78M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sensorion | 68 |
| Adocia | 77 |
| MaaT Pharma | 65 |
| ABIONYX Pharma | 51 |
| OSE Immunotherapeutics | 64 |
| Transgene | 147 |
| Valerio Therapeutics Société anonyme | 25 |
| Cellectis | 222 |
Innate Pharma News
- 15 days ago - Innate Pharma SA: Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Finanz Nachrichten
- 15 days ago - Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Business Wire
- 15 days ago - Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026 - Wallstreet:Online
- 16 days ago - Innate Pharma SA: Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference - Finanz Nachrichten
- 16 days ago - Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference - Business Wire
- 2 months ago - Number of Shares and Voting Rights of Innate Pharma as of December 31, 2025 - Business Wire
- 2 months ago - Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025 - Business Wire
- 3 months ago - Innate Pharma Releases Its 2026 Financial Calendar - Business Wire